Bridging Translation by Improving Preclinical Study Design in AKI - Wikidata - awgldk - TriplyDB

Bridging Translation by Improving Preclinical Study Design in AKI

Bridging Translation by Improving Preclinical Study Design in AKI

http://www.wikidata.org/entity/Q28084530

about

The ten barriers for translation of animal data on AKI to the clinical setting.Bridging translation for acute kidney injury with better preclinical modeling of human disease Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury.Recent early clinical drug development for acute kidney injury.Nanomedicines for renal disease: current status and future applications Cellular plasticity in kidney injury and repair.Understanding and preventing contrast-induced acute kidney injury.Generalizable Biomarkers in Critical Care: Toward Precision Medicine.Models of Human AKI: Resemblance, Reproducibility, and Return on Investment.An intracellular matrix metalloproteinase-2 isoform induces tubular regulated necrosis: implications for acute kidney injury.Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice.Translating Knowledge Into Therapy for Acute Kidney Injury.Remote effects of acute kidney injury in a porcine model.Determination of renal function and injury using near-infrared fluorimetry in experimental cardiorenal syndrome.Selective Nanoparticle Targeting of the Renal Tubules.Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications.CRISPR/Cas9 engineering of a KIM-1 reporter human proximal tubule cell line

P2860

Q36357460-FFF83C94-2DD3-48DA-9157-600E1C3C5D1E Q36957116-BB0C5989-73CB-4E24-A549-E4944C8EB379 Q37291351-884BC0FB-04B8-46B0-B250-9AD937A80515 Q38780169-23BCC599-8C1C-4F67-91F8-400BDA706AB5 Q38802375-C4FD1B33-1A22-4940-920D-13611DD445CC Q39021703-F6009782-749E-4F1B-8323-6724AF43131E Q39110308-98097999-C8D0-4176-BBD9-A48A23FC8F19 Q40210673-4307AAC1-FAD4-411D-B9A3-80B25B346255 Q42631876-878C990D-FFB6-4B38-8F50-EEF5D4C26913 Q46076928-497FB0B3-6FFF-4B02-A5E8-3CDB687897FB Q47139383-A9C35AAC-F91A-42B9-B2E3-F97F1BE0B927 Q47226520-B183E0A8-02EA-433A-9B9A-EFE0DB3E8F30 Q48098176-8404EAAF-F540-4958-885C-00C0334F041A Q48362722-5A5F2FFD-14D7-4EEB-B7A9-F1B6BD62F10B Q48602509-5384625E-C9E4-4383-9411-D6989E649A8E Q52361165-FE97BE91-6768-4A51-9932-0B1993729DCD Q54981618-93155437-66EA-4A9B-9D4E-1D74CA489221 Q58691679-1CE6D494-7C9C-4C9B-8EB3-E29EBB843D36

P2860

Bridging Translation by Improving Preclinical Study Design in AKI

http://www.wikidata.org/entity/Q28084530

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Bridging Translation by Improving Preclinical Study Design in AKI

@ast

Bridging Translation by Improving Preclinical Study Design in AKI

@en

Bridging Translation by Improving Preclinical Study Design in AKI

@nl

type

label

Bridging Translation by Improving Preclinical Study Design in AKI

@ast

Bridging Translation by Improving Preclinical Study Design in AKI

@en

Bridging Translation by Improving Preclinical Study Design in AKI

@nl

prefLabel

Bridging Translation by Improving Preclinical Study Design in AKI

@ast

Bridging Translation by Improving Preclinical Study Design in AKI

@en

Bridging Translation by Improving Preclinical Study Design in AKI

@nl

P1433

Q28084530-B5C93656-6B1A-4C3E-8D90-83A8DA670A68

P1476

Q28084530-94DB60CF-511E-4A7D-9A62-CC47F4C7A695

P2093

Q28084530-27B8B68F-6212-4643-A79F-827169788D65

Q28084530-58D6F998-6804-416E-9C96-8675B7D6C622

Q28084530-8E1A36E8-7100-4AA0-BD8A-2A9E9E46EECC

Q28084530-8EC97A2B-38FF-4176-A8F9-8778599EDD92

Q28084530-90E94284-AA69-4759-89EB-6B5E3FDE3A07

Q28084530-9D8D6915-BD5E-4D25-83BC-FD3367BB3F59

Q28084530-A8732E6B-B25B-4354-8481-BBB97E531B74

Q28084530-AC076801-46B7-471C-83F2-B43A80F86071

Q28084530-C055E30A-690E-43BC-A081-22ECD5EEB663

Q28084530-DDB1C7B8-0EAB-44C3-ABF9-25F108D7312E

P2860

Q28084530-030E00DE-FF59-4C48-B4AD-07C7814FF6B5

Q28084530-06803368-18A4-4C45-88B9-41B25AEE6A07

Q28084530-06B64057-7B63-44FD-8F96-56029980CED4

Q28084530-0DF1EC99-F815-4474-9DD6-7B5C661C46C8

Q28084530-16B5A162-D45F-4712-AA5C-FE0A30FCDBE8

Q28084530-17440FAC-9A4E-4A9A-8E7F-093EE085275F

Q28084530-1D6BF6F4-B0CF-459D-BEED-74A37DAE9B0C

Q28084530-21440F88-CFE7-407A-9555-F4F375BF99B8

Q28084530-215FC229-4A8A-4B33-9108-4046B0A28C03

Q28084530-26EB4344-8A60-4454-B4C2-B3D72D616102

P304

Q28084530-6EB74008-B1EB-4E01-99EE-3AC807AB618F

P31

Q28084530-B38A6553-C432-436B-BEE5-72EE125C64AA

P3181

Q28084530-1ECE4210-34D0-4AB2-A225-30AEB49AD9FB

P356

Q28084530-C92FCE1B-7123-4DDA-AB53-EB024C3ECC38

P407

Q28084530-CBD85B11-DE6F-4001-8E57-99707C6ED359

P433

Q28084530-8477AD58-6AFC-426F-B071-110194655588

P478

Q28084530-E36686B0-E5A8-4C7B-9400-781690C8D78B

P50

Q28084530-1BC6BC32-DA46-4874-9C9F-D85622D7091F

P577

Q28084530-1640BEEF-00E0-4D9F-BB3E-8422F137C694

P698

Q28084530-818F50BB-0EF4-4879-804D-DA14A913AF52

P932

Q28084530-FC89477E-A1A2-469D-B710-7845085B0381

P3181

P356

P1433

Journal of the American Society of Nephrology

P1476

Bridging Translation by Improving Preclinical Study Design in AKI

@en

P2093

ASN AKI Advisory Group

http://www.w3.org/2001/XMLSchema#string

Ben D Humphreys

http://www.w3.org/2001/XMLSchema#string

David Askenazi

http://www.w3.org/2001/XMLSchema#string

Frank E Harrell

http://www.w3.org/2001/XMLSchema#string

Girish Mour

http://www.w3.org/2001/XMLSchema#string

Jorge Cerda

http://www.w3.org/2001/XMLSchema#string

Mark D Okusa

http://www.w3.org/2001/XMLSchema#string

Mark de Caestecker

http://www.w3.org/2001/XMLSchema#string

Nick Pullen

http://www.w3.org/2001/XMLSchema#string

Sarah Faubel

http://www.w3.org/2001/XMLSchema#string

P2860

A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic

Drug development: Raise standards for preclinical cancer research

Systematic Reviews of Preclinical Animal Studies can Make Significant Contributions to Health Care and More Transparent Translational Medicine

Tracking replicability as a method of post-publication open evaluation

A call for transparent reporting to optimize the predictive value of preclinical research

Reproducibility of results in preclinical studies: a perspective from the bone field

Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

The Economics of Reproducibility in Preclinical Research

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

Believe it or not: how much can we rely on published data on potential drug targets?

P304

2905-2916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3307812

http://www.w3.org/2001/XMLSchema#string

P356

10.1681/ASN.2015070832

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26538634

http://www.w3.org/2001/XMLSchema#string

P932

4657852

http://www.w3.org/2001/XMLSchema#string